MRK Q1 Earnings & Sales Beat Estimates, 2026 Sales View TightenedZacks Investment Research • 04/30/26
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 04/30/26
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin ManifestationsBusiness Wire • 04/30/26
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlookCNBC • 04/30/26
Dow Jones' Merck Tops Forecasts, But Growth Products Come Up MixedInvestors Business Daily • 04/30/26
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical MilestonesBusiness Wire • 04/30/26
Merck's Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or StrokeBusiness Wire • 04/28/26
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 04/27/26
Exploring Analyst Estimates for Merck (MRK) Q1 Earnings, Beyond Revenue and EPSZacks Investment Research • 04/27/26
Will Lower Gardasil Sales Hurt MRK's Vaccines Sales in Q1 Earnings?Zacks Investment Research • 04/24/26
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.Business Wire • 04/24/26
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/23/26
MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer StudyZacks Investment Research • 04/22/26
Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise TransformationPRNewsWire • 04/22/26